| 000 | 01522 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517032223.0 | ||
| 264 | 0 | _c20150930 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a1096-8652 | ||
| 024 | 7 |
_a10.1002/ajh.24047 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFattizzo, Bruno | |
| 245 | 0 | 0 |
_aLessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias. _h[electronic resource] |
| 260 |
_bAmerican journal of hematology _cAug 2015 |
||
| 300 |
_aE149-51 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAnemia, Hemolytic, Autoimmune _xblood |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
| 650 | 0 | 4 |
_aErythrocytes _xdrug effects |
| 650 | 0 | 4 | _aHemolysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 | _aLenalidomide |
| 650 | 0 | 4 | _aPlasma Exchange |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSplenectomy |
| 650 | 0 | 4 |
_aSteroids _xtherapeutic use |
| 650 | 0 | 4 |
_aThalidomide _xanalogs & derivatives |
| 650 | 0 | 4 | _aTime-to-Treatment |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aZaninoni, Anna | |
| 700 | 1 | _aNesa, Francesco | |
| 700 | 1 | _aSciumbata, Veronica M | |
| 700 | 1 | _aZanella, Alberto | |
| 700 | 1 | _aCortelezzi, Agostino | |
| 700 | 1 | _aBarcellini, Wilma | |
| 773 | 0 |
_tAmerican journal of hematology _gvol. 90 _gno. 8 _gp. E149-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.24047 _zAvailable from publisher's website |
| 999 |
_c24890249 _d24890249 |
||